Ptc Therapeutics reported $71K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Amgen AMGN:US USD 32.37B 1.03B
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Cytokinetics CYTK:US USD 93K 8K
Daiichi Sankyo 4568:JP JPY 50B 0
Esperion Therapeutics ESPR:US USD 72K 7K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
IONIS PHARMACEUT IONS:US USD 142K 0
Ironwood Pharmaceuticals IRWD:US USD 153K 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Novartis NOVN:VX USD 878.25M 11.75M
Ptc Therapeutics PTCT:US USD 71K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
Tg Therapeutics TGTX:US USD 145K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Xencor XNCR:US USD 598K 0
YTE INCY:US USD 222K 0